Mineral Ice
Executive Summary
Bristol-Myers purchases the OTC topical analgesic brand from The Biopractic Group. The second leading topical analgesic in the U.S., behind Pfizer's Ben-Gay, the gel product will complement Bristol's presence in the internal analgesic market with the Bufferin, Nuprin and Excedrin brands. Previously, Mineral Ice was distributed through brokers....